ONMD Stock Risk & Deep Value Analysis
Onemednet Corp
Healthcare • Health Information Services
DVR Score
out of 10
What You Need to Know About ONMD Stock
We analyzed Onemednet Corp using our deep value framework. Sign in to see our full verdict and DVR Score.
We ran ONMD through our deep value framework — analyzing financial health, distress signals, competitive moat, and risk factors. Our risk assessment: Aggressive. Here's what we found.
ONMD Risk Analysis & Red Flags
What Could Go Wrong
The company faces an imminent liquidity crisis due to critically high cash burn and minimal revenue. Without securing substantial additional funding or dramatically cutting costs, it risks bankruptcy or massive shareholder dilution that could render existing equity near worthless.
Risk Matrix
Overall
Aggressive
Financial
High
Market
Medium
Competitive
Medium
Execution
High
Regulatory
Low
Red Flags
- ⚠
Critically high cash burn with limited runway
- ⚠
Persistent negative revenue growth or stagnation
- ⚠
Ongoing share dilution without clear path to profitability
- ⚠
Market cap is $0.05B, trading as a penny stock ($0.8874)
Upcoming Risk Events
- 📅
Failure to secure additional funding leading to liquidity crisis
- 📅
Accelerated share dilution without corresponding business growth
- 📅
Potential delisting from exchange due to low share price or non-compliance
When to Reconsider
- 🚪
Failure to announce new funding by Q2 2026
- 🚪
Cash burn accelerates further or cash balance drops below $5M
- 🚪
Further significant share dilution (e.g., >20% increase in outstanding shares) without material revenue growth
Unlock ONMD Risk Analysis & Red Flags
Create a free account to see the full analysis
What Does Onemednet Corp (ONMD) Do?
Sector
Healthcare
Industry
Health Information Services
Employees
22
OneMedNet Corporation, a healthcare software company, provides digital medical image management, exchange, and sharing solutions in the Americas, Europe, and the Middle East. The company offers iRWD, which provides regulatory grade imaging and clinical data in the pharmaceutical, device manufacturing, contract research organizations, and artificial intelligence markets markets; and BEAM, a medical imaging exchange platform between hospital/healthcare systems, imaging centers, physicians, and patients. OneMedNet Corporation is headquartered in Eden Prairie, Minnesota.
Visit Onemednet Corp WebsiteInvestment Thesis
ONMD is a highly speculative, high-risk bet on a distressed micro-cap company operating in the promising RWD/iRWD market. The investment thesis hinges entirely on the company's ability to successfully secure critical financing, significantly reduce its cash burn, and execute a rapid turnaround to capture market share, transforming its unproven technological potential into a viable, profitable business within the next 3-5 years. This is a lottery ticket, not an investment.
Is ONMD Stock Undervalued?
Unlock the full AI analysis for ONMD
Get the complete DVR score, risk analysis, and more
Unlock the full report
Create a free account to see the DVR score, risk flags, and AI analysis.
ONMD Price Targets & Strategy
12-Month Target
$0.40
Bull Case
$1.50
Bear Case
$0.10
Valuation Basis
Base target reflects severe financial distress and high likelihood of further dilution, assuming a distressed equity value; upside requires significant, successful funding and operational pivot, while downside anticipates potential bankruptcy or near-complete capital wipeout.
Entry Strategy
Extremely speculative. Only consider small, 'loss-tolerable' capital on significant positive news regarding funding or operational changes, ideally below current price and near historical lows if any. Not recommended for typical investors.
Exit Strategy
Take profit on any significant short-term rallies driven by speculative news (e.g., 50%+ gain). Stop loss below $0.20 if company fails to secure funding or shows accelerated cash burn.
Portfolio Allocation
0.1% for aggressive, highly speculative portfolios (equivalent to a venture-capital type bet).
Price Targets & Strategy
Upgrade to Premium for price targets and entry/exit strategies
Does ONMD Have a Competitive Moat?
Sign in to unlockMoat Rating
⚪ None
Moat Trend
Eroding
Moat Sources
1 Identified
The potential intellectual property and niche focus may offer a theoretical moat, but it is not durable without significant capital investment, successful execution, and a stable financial footing. Current financial distress actively erodes any potential moat.
Moat Erosion Risks
- •Inability to fund IP development and commercialization
- •Established competitors with greater resources, data sets, and market reach
- •Lack of market adoption for their specific iRWD™ solutions
ONMD Competitive Moat Analysis
Sign up to see competitive advantages
ONMD Market Intelligence
Sentiment & Insider Activity
Social Sentiment
Bearish (due to financial distress, highly speculative retail interest)
Institutional Sentiment
Negative (likely minimal institutional holdings given financials and market cap)
Insider Activity (Form 4)
No specific insider buying or selling activity reported recently in the provided context.
Options Flow
Normal options activity (likely limited options market given micro-cap status).
Earnings Intelligence
Next Earnings
Estimated late April 2026 (for Q1 2026 results)
Surprise Probability
High (significant volatility and uncertainty around financial performance)
Historical Earnings Pattern
Likely highly volatile reactions to earnings, with significant price swings dependent on funding news and cash burn figures rather than traditional revenue/EPS beats.
Key Metrics to Watch
Competitive Position
Top Competitor
IQV (IQVIA Holdings Inc.)
Market Share Trend
Negligible/Stable (not actively gaining significant market share due to financial constraints)
Valuation vs Peers
Incomparable due to negative/minimal revenue and earnings; any valuation would be speculative against peers with established business models.
Competitive Advantages
- •Potential proprietary iRWD™ technology (unproven scale)
- •Niche focus within a high-growth data market
Market Intelligence
Get sentiment, earnings intel, and peer analysis with Premium
What Could Drive ONMD Stock Higher?
Near-Term (0-6 months)
- •Announcement of successful, non-dilutive financing round (highly unlikely currently)
- •Material reduction in quarterly cash burn
Medium-Term (6-18 months)
- •Significant commercial contract wins that show accelerated revenue growth
- •Strategic partnership with a major pharmaceutical or healthcare entity
Long-Term (18+ months)
- •Achieving sustainable positive free cash flow and profitability
- •Demonstrating clear market leadership in a niche iRWD segment
Catalysts & Growth Drivers
Upgrade to Premium to see catalysts
What's the Bull Case for ONMD?
- ✓
Clear and sustainable reduction in quarterly cash burn
- ✓
Announcement of a substantial, non-dilutive (or minimally dilutive) funding round
- ✓
Significant acceleration in revenue growth (e.g., consecutive quarters of 50%+ sequential growth)
Bull Case Analysis
See what could go right with Premium
Competing with ONMD
See how Onemednet Corp compares to related companies
| Company | Market Cap | DVR Score | P/E | Revenue | Profit Margin | Rev Growth | |
|---|---|---|---|---|---|---|---|
Onemednet Corp ONMD | — | 1.0 | — | — | — | — | |
AbbVie Inc ABBV | $403.8B | 0.1 | 171.8 | — | — | — | Compare → |
Johnson & Johnson JNJ | — | 1.0 | — | — | — | — | Compare → |
Eli Lilly and Co LLY | $965.0B | 0.5 | 52.6 | — | — | — | Compare → |
Pfizer Inc PFE | $150.6B | 0.2 | 19.4 | $62.6B | 12.4% | -1.6% | Compare → |
UnitedHealth Group Inc UNH | $276.2B | 0.3 | 22.9 | $113.7B | 2.7% | 1181.0% | Compare → |
📊 Explore More Stock Analysis
Get comprehensive Deep Value Reports for thousands of stocks. Research risk, financial health, and investment potential with our AI-powered analysis.
FAQ
What is the DVR Score for Onemednet Corp (ONMD)?
As of March 30, 2026, Onemednet Corp has a DVR Score of 1.0 out of 10, placing it in the "Distressed" category. This score is generated by our AI-powered deep value analysis framework that evaluates growth potential, financial health, competitive moat, and risk factors.
What ticker symbol does Onemednet Corp use?
ONMD is the ticker symbol for Onemednet Corp. The company trades on the NCM.
What is the risk level for ONMD stock?
Our analysis rates Onemednet Corp's overall risk as Aggressive. This assessment considers execution risk, market risk, financial risk, competitive risk, and regulatory risk. For a full breakdown, see the risk analysis section above.
How often is the ONMD DVR analysis updated?
Our AI-powered analysis of Onemednet Corp is refreshed regularly to incorporate the latest financial data, market conditions, and news. The most recent update was on March 30, 2026.
Important Disclaimer – Not Financial Advice
Deep Value Reports is an independent research platform for educational and informational purposes only. We are not financial advisors, investment advisors, or licensed professionals. The analysis, scores, and information provided on this page for ONMD (Onemednet Corp) should not be construed as personalized investment advice, a recommendation to buy or sell any security, or an offer to provide investment advisory services.
All investments involve risk, including the potential loss of principal. Past performance does not guarantee future results. Always conduct your own research, consider your financial situation, and consult with a qualified financial advisor before making any investment decisions.